Huron Consulting Group (HURN) to Release Earnings on Tuesday

Huron Consulting Group (NASDAQ:HURN) is scheduled to be releasing its earnings data after the market closes on Tuesday, April 30th. Analysts expect Huron Consulting Group to post earnings of $0.88 per share for the quarter. Huron Consulting Group has set its FY24 guidance at $5.35-5.95 EPS and its FY 2024 guidance at 5.350-5.950 EPS.Investors interested in registering for the company’s conference call can do so using this link.

Huron Consulting Group (NASDAQ:HURN) last released its earnings results on Tuesday, February 27th. The business services provider reported $1.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.12 by $0.17. The company had revenue of $339.23 million for the quarter, compared to analyst estimates of $341.71 million. Huron Consulting Group had a net margin of 4.47% and a return on equity of 17.77%. The firm’s quarterly revenue was up 8.1% on a year-over-year basis. During the same period in the prior year, the business earned $1.12 EPS. On average, analysts expect Huron Consulting Group to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Huron Consulting Group Price Performance

Huron Consulting Group stock opened at $93.63 on Friday. The firm has a market cap of $1.73 billion, a PE ratio of 29.26 and a beta of 0.58. Huron Consulting Group has a 52-week low of $70.66 and a 52-week high of $113.31. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.61. The company’s 50 day moving average is $96.67 and its two-hundred day moving average is $100.80.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on HURN shares. StockNews.com lowered shares of Huron Consulting Group from a “buy” rating to a “hold” rating in a report on Wednesday, February 28th. Barrington Research increased their target price on shares of Huron Consulting Group from $128.00 to $133.00 and gave the stock an “outperform” rating in a report on Wednesday, March 6th.

Insider Activity

In other news, Director John Mccartney sold 300 shares of the firm’s stock in a transaction on Friday, March 1st. The shares were sold at an average price of $98.13, for a total value of $29,439.00. Following the sale, the director now directly owns 56,919 shares in the company, valued at approximately $5,585,461.47. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director James H. Roth sold 9,517 shares of the stock in a transaction on Monday, March 4th. The shares were sold at an average price of $99.28, for a total value of $944,847.76. Following the transaction, the director now directly owns 83,239 shares of the company’s stock, valued at approximately $8,263,967.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director John Mccartney sold 300 shares of the stock in a transaction on Friday, March 1st. The shares were sold at an average price of $98.13, for a total transaction of $29,439.00. Following the completion of the transaction, the director now directly owns 56,919 shares in the company, valued at $5,585,461.47. The disclosure for this sale can be found here. In the last three months, insiders have sold 42,080 shares of company stock worth $4,146,076. 2.02% of the stock is currently owned by corporate insiders.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.